We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Medical Management of Frontotemporal Dementia.
- Authors
Caselli, Richard J.; Yaari, Roy
- Abstract
There are no Food and Drug Administration (FDA)-approved medications for the medical management of frontotemporal dementia and its related disorders, so all management recommendations are necessarily off-label and borrowed from experience with Alzheimer's disease, psychiatric disease, and related medical illnesses. Six areas of pharmacotherapeutic consideration are prevention (primary and secondary), intellectual decline, behavioral disorders (such as depression, anxiety, and psychosis), sleep disorders, frequently associated disorders (including motor neuron disease), and abrupt decline. In addition to pharmacotherapy, important lifestyle issues confronting the clinician include driving cessation, securing any weapons maintained at home, assisted living, and caregiver burnout.
- Subjects
DISEASE management; TREATMENT of dementia; DRUG therapy for psychoses; BEHAVIOR disorders; SLEEP disorders; LIFESTYLES
- Publication
American Journal of Alzheimer's Disease & Other Dementias, 2007, Vol 22, Issue 6, p489
- ISSN
1533-3175
- Publication type
Article